ILK Inhibition Reduces Osteophyte Formation Through Suppression of Osteogenesis in BMSCs Via Akt/GSK-3β/β-catenin Pathway

Overview

Journal Mol Biol Rep

Specialty Molecular Biology

Date 2024 Mar 14

PMID 38483756

Authors

Zhixiang Huang

Lixin Huang

Jiali Ding

Yukai Huang

Xuechan Huang

Tianwang Li

Affiliations

Soon will be listed here.

Abstract

Background: Osteophyte development is a common characteristic of inflammatory skeletal diseases. Elevated osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) participates in pathological osteogenesis. Integrin-linked kinase (ILK) positively regulates the osteoblastic differentiation of osteoprogenitors, but whether the ILK blockage prevents osteophytes and its potential mechanism is still unknown. Furthermore, the low-dose tumor necrosis factor-α (TNF-α) promotes osteogenic differentiation, but a lack of study reports on the relationship between this cytokine and ILK. OSU-T315 is a small ILK inhibitor, which was used to determine the effect of ILK inhibition on osteogenesis and osteophyte formation.

Methods And Results: The osteogenesis of BMSCs was evaluated using Alizarin red S staining, alkaline phosphatase, collagen type I alpha 2 chain, and bone gamma-carboxyglutamate protein. The expression and phosphorylation of protein were assessed through western blot. Immunofluorescence was employed to display the distribution of β-catenin. microCT, hematoxylin-eosin, and safranin O/fast green staining were utilized to observe the osteophyte formation in collagen antibody-induced arthritis mice. We found that ILK blockage significantly declined calcium deposition and osteoblastic markers in a dose- and time-dependent manner. Furthermore, it lowered osteogenesis in the TNF-α-induced inflammatory microenvironment by diminishing the effect of ILK and inactivating the Akt/ GSK-3β/ β-catenin pathway. Nuclear β-catenin was descended by OSU-T315 as well. Finally, the ILK suppression restrained osteophyte formation but not inflammation in vivo.

Conclusions: ILK inhibition lowered osteogenesis in TNF-α-related inflammatory conditions by deactivating the Akt/ GSK-3β/ β-catenin pathway. This may be a potential strategy to alleviate osteophyte development in addition to anti-inflammatory treatment.

Citing Articles

Anaerobic metabolism promotes breast cancer survival via Histone-3 Lysine-18 lactylation mediating PPARD axis.

Xu Y, Meng W, Dai Y, Xu L, Ding N, Zhang J Cell Death Discov. 2025; 11(1):54.

PMID: 39922804 PMC: 11807217. DOI: 10.1038/s41420-025-02334-x.

References

Tay S, Yeo J, Leong J, Albani S, Arkachaisri T . Juvenile Spondyloarthritis: What More Do We Know About HLA-B27, Enthesitis, and New Bone Formation?. Front Med (Lausanne). 2021; 8:666772. PMC: 8174582. DOI: 10.3389/fmed.2021.666772. View

Berthelot J, Le Goff B, Maugars Y . Bone marrow mesenchymal stem cells in rheumatoid arthritis, spondyloarthritis, and ankylosing spondylitis: problems rather than solutions?. Arthritis Res Ther. 2019; 21(1):239. PMC: 6854713. DOI: 10.1186/s13075-019-2014-8. View

Zheng C, Hu H, Hong P, Zhang Q, Xu W, He Q . Significance of integrin-linked kinase (ILK) in tumorigenesis and its potential implication as a biomarker and therapeutic target for human cancer. Am J Cancer Res. 2019; 9(1):186-197. PMC: 6356918. View

Yoganathan T, Costello P, Chen X, Jabali M, Yan J, Leung D . Integrin-linked kinase (ILK): a "hot" therapeutic target. Biochem Pharmacol. 2000; 60(8):1115-9. DOI: 10.1016/s0006-2952(00)00444-5. View

Lu X, Chen Y, Mao P, Chen L, Han X, Sun F . Nanoparticle Shaped Titanium Promotes Osteogenic Differentiation of Bone Mesenchymal Stem Cells Through Integrin/Integrin Linked Kinase/Glycogen Synthase Kinase-3 Axis. J Biomed Nanotechnol. 2021; 16(8):1267-1275. DOI: 10.1166/jbn.2020.2957. View

Traister A, Aafaqi S, Masse S, Dai X, Li M, Hinek A . ILK induces cardiomyogenesis in the human heart. PLoS One. 2012; 7(5):e37802. PMC: 3362604. DOI: 10.1371/journal.pone.0037802. View

Ma D, Chen H, Ma K, Lai J, Yang U, Yeh L . Preservation of human limbal epithelial progenitor cells on carbodiimide cross-linked amniotic membrane via integrin-linked kinase-mediated Wnt activation. Acta Biomater. 2015; 31:144-155. DOI: 10.1016/j.actbio.2015.11.042. View

Lee S, Hsu E, Chou C, Chuang H, Bai L, Kulp S . Identification and characterization of a novel integrin-linked kinase inhibitor. J Med Chem. 2011; 54(18):6364-74. PMC: 3182772. DOI: 10.1021/jm2007744. View

Shirley L, McCarty S, Yang M, Saji M, Zhang X, Phay J . Integrin-linked kinase affects signaling pathways and migration in thyroid cancer cells and is a potential therapeutic target. Surgery. 2015; 159(1):163-70. PMC: 4961251. DOI: 10.1016/j.surg.2015.10.016. View

10.

Mercado-Pimentel M, Igarashi S, Dunn A, Behbahani M, Miller C, Read C . The Novel Small Molecule Inhibitor, OSU-T315, Suppresses Vestibular Schwannoma and Meningioma Growth by Inhibiting PDK2 Function in the AKT Pathway Activation. Austin J Med Oncol. 2016; 3(1). PMC: 5024787. View

11.

Van Belle K, Herman J, Waer M, Sprangers B, Louat T . OSU-T315 as an Interesting Lead Molecule for Novel B Cell-Specific Therapeutics. J Immunol Res. 2018; 2018:2505818. PMC: 6157143. DOI: 10.1155/2018/2505818. View

12.

Huang H, Wu H, Chu P, Lai I, Huang P, Kulp S . Role of integrin-linked kinase in regulating the protein stability of the MUC1-C oncoprotein in pancreatic cancer cells. Oncogenesis. 2017; 6(7):e359. PMC: 5541713. DOI: 10.1038/oncsis.2017.61. View

13.

Muth K, Rech J, Losch F, Hoerning A . Reversing the Inflammatory Process-25 Years of Tumor Necrosis Factor-α Inhibitors. J Clin Med. 2023; 12(15). PMC: 10419406. DOI: 10.3390/jcm12155039. View

14.

Wang Y, Xu D, Liu Y, Zhang R, Lu L . The Effect of Tumor Necrosis Factor-α at Different Concentrations on Osteogenetic Differentiation of Bone Marrow Mesenchymal Stem Cells. J Craniofac Surg. 2015; 26(7):2081-5. DOI: 10.1097/SCS.0000000000001971. View

15.

Yue Y, Wang C, Benedict C, Huang G, Truongcao M, Roy R . Interleukin-10 Deficiency Alters Endothelial Progenitor Cell-Derived Exosome Reparative Effect on Myocardial Repair via Integrin-Linked Kinase Enrichment. Circ Res. 2019; 126(3):315-329. PMC: 7015105. DOI: 10.1161/CIRCRESAHA.119.315829. View

16.

Li Y, Yuan L, Jiang S, Liu S, Xia L, Shen H . Interleukin-35 stimulates tumor necrosis factor-α activated osteoblasts differentiation through Wnt/β-catenin signaling pathway in rheumatoid arthritis. Int Immunopharmacol. 2019; 75:105810. DOI: 10.1016/j.intimp.2019.105810. View

17.

Chen H, Cheng M, Gao P, Zhang X, Li G, Wang L . GDC-0941 activates integrin linked kinase (ILK) expression to cause resistance to GDC-0941 in breast cancer by the tumor necrosis factor (TNF)-α signaling pathway. Bioengineered. 2022; 13(4):10944-10955. PMC: 9208486. DOI: 10.1080/21655979.2022.2066758. View

18.

Wu F, Chen J, Fan L, Liu K, Zhang N, Li S . Analysis of the effect of rutin on GSK-3β and TNF-α expression in lung cancer. Exp Ther Med. 2017; 14(1):127-130. PMC: 5488604. DOI: 10.3892/etm.2017.4494. View

19.

Li Z, Chen S, Cui H, Li X, Chen D, Hao W . Tenascin-C-mediated suppression of extracellular matrix adhesion force promotes entheseal new bone formation through activation of Hippo signalling in ankylosing spondylitis. Ann Rheum Dis. 2021; 80(7):891-902. PMC: 8237173. DOI: 10.1136/annrheumdis-2021-220002. View

20.

Chiu C, Weng J, Jadhav A, Wu C, Sargeant A, Bai L . T315 Decreases Acute Myeloid Leukemia Cell Viability through a Combination of Apoptosis Induction and Autophagic Cell Death. Int J Mol Sci. 2016; 17(8). PMC: 5000734. DOI: 10.3390/ijms17081337. View